SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 151 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2024. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $231,166 | -53.0% | 42,338 | -13.9% | 0.01% | -50.0% |
Q1 2024 | $491,960 | +102.0% | 49,196 | -17.6% | 0.01% | +100.0% |
Q4 2023 | $243,589 | +5.4% | 59,703 | 0.0% | 0.01% | 0.0% |
Q3 2023 | $231,051 | -35.1% | 59,703 | -0.0% | 0.01% | -28.6% |
Q2 2023 | $355,967 | +91.3% | 59,726 | +4.9% | 0.01% | +75.0% |
Q1 2023 | $186,113 | -17.2% | 56,915 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $224,815 | -33.5% | 56,915 | +1.2% | 0.00% | -42.9% |
Q3 2022 | $338,000 | -6.6% | 56,215 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $362,000 | +13.1% | 56,215 | +45.3% | 0.01% | +40.0% |
Q1 2022 | $320,000 | – | 38,686 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trustees of Columbia University in the City of New York | 281,250 | $6,334,000 | 9.69% |
Flagship Pioneering Inc. | 34,239,018 | $771,063,000 | 8.08% |
Crestline Management, LP | 3,210,937 | $72,310,000 | 6.80% |
SB Management Ltd | 2,209,004 | $49,747,000 | 5.10% |
Omega Fund Management, LLC | 843,750 | $19,001,000 | 2.13% |
HARVARD MANAGEMENT CO INC | 1,163,601 | $26,204,000 | 1.54% |
Alphabet Inc. | 2,812,500 | $63,338,000 | 1.50% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 387,508 | $8,727,000 | 1.03% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $93,036,000 | 0.53% |
Dragoneer Investment Group | 1,500,000 | $33,780,000 | 0.44% |